ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2025
Applying Multiple Analyses to Quantify Changes in the Global, Regional, and National Burden of Tuberculosis From 1990 to 2021 and the Forecast Until 2035.
Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Comprehensive assessments of changes in the burden of tuberculosis (TB) can inform health strategies. Methods: Disability-adjusted life years (DALYs) data were obtained from the Global Burden of Disease database. We used estimated annual percentage changes (EAPCs) to evaluate trends; decomposition analysis to examine the effects of population growth, aging, and epidemiological changes; age-period-cohort model to measure the age, period, and cohort effect; health inequality analysis to assess absolute and relative inequalities; frontier analysis to explore the lowest potential achievable burden based on sociodemographic index (SDI); and Bayesian age-period-cohort model to project future trends. Results: Central Asia (EAPC, 7.82, 95% confidence interval [CI], 6.24-9.43) and Eastern Europe (EAPC, 9.42, 95% CI, 7.33-11.55) had notable increases in TB-related DALYs from 1990 to 1999. Globally, the contributions of population aging, growth, and epidemiological change of TB burden from 1990 to 2021 were -17.29%, -77.75%, and 195.04%, respectively. Children aged 0-4 years have an extremely high risk of TB-related DALYs. Period and cohort effects of TB continuously declined. The slope index of inequality increased from -5183.27 (95% CI, -5636.08 to -4730.46) in 1990 to -1729.88 (95% CI, -1927.35 to -1532.41) in 2021, suggesting a reduction in absolute socioeconomic inequality. Nevertheless, the concentration index showed a minimal decrease from -0.516 (95% CI, -0.571 to -0.461) in 1990 to -0.532 (95% CI, -0.603 to -0.461) in 2021, indicating an increase in relative socioeconomic inequality. Most regions have substantial potential to reduce their TB burden, with the Central African Republic having the highest potential. For low-SDI countries, Niger may serve as an exemplar, and poverty elimination could have profound effects. The burden of TB is projected to decline, but it is unlikely to meet the goals of the End TB Strategy. Conclusion: TB continues to pose a critical health challenge that necessitates the implementation of effective control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.